Stockscreener 앱 받기
2.95
1.34%
-0.04
시장 영업 전:
2.90
-0.05
-1.69%
전일 마감가:
$2.99
열려 있는:
$3.01
하루 거래량:
29,229
Relative Volume:
0.30
시가총액:
$7.26M
수익:
$77,900
순이익/손실:
$-8.05M
주가수익비율:
-0.3196
EPS:
-9.2296
순현금흐름:
$-7.47M
1주 성능:
-2.32%
1개월 성능:
-12.20%
6개월 성능:
-63.89%
1년 성능:
-61.24%
1일 변동 폭
$2.90
$3.0439
1주일 범위
$2.90
$3.17
52주 변동 폭
$2.3401
$12.03
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, HNGE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.95 | 7.26M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
188.17 | 30.57B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
70.50 | 13.84B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
57.27 | 10.28B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
94.73 | 7.92B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.50 | 6.85B | 646.34M | -512.40M | 202.76M | -6.6871 |
Aclarion Inc 주식(ACON)의 최신 뉴스
Aclarion Announces Texas Spine Care Center as New CLARITY Site - marketscreener.com
Aclarion adds Texas Spine Care Center to CLARITY trial - Investing.com
Aclarion adds Texas Spine Care Center to CLARITY trial By Investing.com - Investing.com Canada
Aclarion expands CLARITY trial with Texas spine center - Stock Titan
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
ACON Q1 2026 Earnings: EPS Surpasses Analyst Estimates Despite Lack of Revenue DisclosureFull Year Guidance - dars.gov.et
Enterprise value to EBIT forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
Price to book forward of Aclarion, Inc. – NASDAQ:ACON - TradingView
A412BH Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion, Inc. Actuals & Estimates (NASDAQ:ACON) - TradingView
ACON Forecast — Price Target — Prediction for 2027 - TradingView
Aclarion Inc (ACONW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates with 15% Beat Despite No RevenueGAAP Earnings Report - dars.gov.et
Aclarion Inc (ACONW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc. Warrant (ACONW) Surges 38% From Penny Levels – But Caution WarrantedBPI Bull Correction - Město Břeclav
Aclarion Inc. Holds Steady Near Key Resistance Level (ACON)RTH Profile - dars.gov.et
Aclarion (ACON) upgraded to buy: Here's why - MSN
Aclarion Inc (ACONW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACONW) Institutional Confidence - TradingKey
Aclarion Inc (ACONW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACONW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACONW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACONW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion Inc (ACONW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aclarion board rejects Echo Lake’s $4 per share takeover bid By Investing.com - Investing.com Nigeria
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Surpasses Estimates Despite Ongoing Revenue AbsenceEarnings Season Outlook - newsline.com
Aclarion Inc. (ACON) Slides Amid Light Trading, Support at $2.96 in FocusTRIN Signal - newsline.com
Aclarion (ACON) Chief Strategy Officer granted 55,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) director receives 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (NASDAQ: ACON) director receives 20,000 RSU equity grant - Stock Titan
Aclarion (ACON) CFO awarded 50,000 restricted stock units set to vest 2027 - Stock Titan
Aclarion (ACON) CEO Brent Ness receives 100,000 RSU equity award - Stock Titan
Aclarion (ACON) director awarded 20,000 RSUs vesting in 2027 - Stock Titan
Aclarion (ACON) grants 100,000 RSUs to Executive Chairman Thramann - Stock Titan
Aclarion (ACON) director receives 20,000 RSU equity award, total holdings 22,502 shares - Stock Titan
Director granted 20,000 RSUs at Aclarion (NASDAQ: ACON) vesting 2027 - Stock Titan
ACON Q1 2026 Earnings: EPS Beats Estimates Despite No Revenue ReportedMargin Expansion Trends - newsline.com
ACONW Warrants Surge Over 10%: A Closer Look at the Microcap MoveValue Area High - newsline.com
Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform - Ortho Spine News
Aclarion Inc. (ACON) Consolidates Near Key Support After Marginal DeclinePrice Target - newsline.com
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub - The Manila Times
Triple-digit Nociscan growth as Aclarion presents back-pain tech in Vegas - Stock Titan
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aclarion Inc 주식 (ACON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
4.18%
자본화:
|
볼륨(24시간):